Interní Med. 2017; 19(2): 54-56 | DOI: 10.36290/int.2017.009

Diabetology: a field of new possibilities

MUDr. Marcela Szabó

Diabetologická a obezitologická ambulance Poliklinika Barrandov, Praha

In the recent years, diabetology has been among the most dynamically developing branches of medicine. This has been contributed

to by the introduction of both novel drugs and technologies into common clinical practice. In particular, it is the treatment

of type 2 diabetes that is undergoing a major transformation, wherein the state-of-the-art medications include incretin-based

drugs and sodium–glucose co-transporter inhibitors. However, novel drugs have also provided a new perspective on the efficacy

and safety of treatment as well as on the therapeutic goals. Currently, the goals of diabetes treatment include not only improved

diabetes control, i.e. decreasing the level of glycated haemoglobin by preventing preprandial and postprandial hyperglycaemia,

thereby reducing the risk of development and progression of long-term diabetes complications. Novel antidiabetic drugs also

favourably affect patient weight and blood pressure as well as reduce the risk of heart failure. Special attention is paid to treatment

safety, particularly in terms of reducing the risk of developing hypoglycaemia.

Keywords: incretin-based drugs, sodium–glucose co-transporter inhibitors, comprehensive effect, treatment safety, clinical trials

Published: April 1, 2017  Show citation